Aprameya Engineering P/E Ratio
Aprameya Engineering (APRAMEYA) P/E ratio is 28.66 (High), EPS (TTM) ₹9.27, current price ₹ on None — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see Aprameya Engineering share price chart.
Current P/E Ratio
28.66
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
28.66
Current Price
₹
EPS (TTM)
₹9.27
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.74
Sector Median
27.37
Sector Rank
#11 of 192
Sector Percentile
5.7%
APRAMEYA P/E Ratio — Valuation Signal & Historical Context
Aprameya Engineering P/E 28.66 — signal: Overvalued. Analyse APRAMEYA shareholding pattern to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 28.66, suggesting caution for new investments
- Trading at discount to sector average PE of 53.74
APRAMEYA vs Healthcare Peers — P/E Ratio Comparison
Aprameya Engineering P/E 28.66 vs Healthcare average 53.74, median 27.37 — range 1.03–1007.14.
Sector Average
53.74
Sector Median
27.37
Lowest P/E
1.03
Highest P/E
1007.14
Companies
192
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.71 | ₹71 | Low |
| Shelter Pharma | SHELTER | 6.75 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹23 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹74 | Low |
| Par Drugs & Chemical | PAR | 8.21 | ₹114 | Low |
| Medicamen Organics | MEDIORG | 8.76 | ₹35 | Low |